Skip Nav Destination
Issues
1 March 2009
-
Cover Image
Cover Image
Hematoxylin and eosin stain of an oropharyngeal squamous cell carcinoma, representing a cohort of patients treated with cisplatin-based concurrent chemoradiation. Bcl-2 was identified as an independent predictor of treatment failure, with a hazard ratio of 5.99 (P < 0.0014). For further details, please see the article by Michaud and colleagues on page 1645 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
CCR Translations
Molecular Pathways
Human Cancer Biology
Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion
Michaela Wrage; Salla Ruosaari; Paul P. Eijk; Jussuf T. Kaifi; Jaakko Hollmén; Emre F. Yekebas; Jakob R. Izbicki; Ruud H. Brakenhoff; Thomas Streichert; Sabine Riethdorf; Markus Glatzel; Bauke Ylstra; Klaus Pantel; Harriet Wikman
Cancer Therapy: Preclinical
Treatment of Mammary Carcinomas in HER-2 Transgenic Mice through Combination of Genetic Vaccine and an Agonist of Toll-Like Receptor 9
Luigi Aurisicchio; Daniela Peruzzi; Antonella Conforti; Sridhar Dharmapuri; Antonella Biondo; Saverio Giampaoli; Arthur Fridman; Ansu Bagchi; Christopher T. Winkelmann; Raymond Gibson; Ekambar R. Kandimalla; Sudhir Agrawal; Gennaro Ciliberto; Nicola La Monica
Suppression of Tumor Growth In vivo by the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II
Lan-Feng Dong; Ruth Freeman; Ji Liu; Renata Zobalova; Alvaro Marin-Hernandez; Marina Stantic; Jakub Rohlena; Karel Valis; Sara Rodriguez-Enriquez; Bevan Butcher; Jacob Goodwin; Ulf T. Brunk; Paul K. Witting; Rafael Moreno-Sanchez; Immo E. Scheffler; Stephen J. Ralph; Jiri Neuzil
mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
Heidi A. Lane; Jeanette M. Wood; Paul M.J. McSheehy; Peter R. Allegrini; Anne Boulay; Joseph Brueggen; Amanda Littlewood-Evans; Sauveur-Michel Maira; Georg Martiny-Baron; Christian R. Schnell; Patrizia Sini; Terence O'Reilly
Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
William A. Michaud; Anthony C. Nichols; Edmund A. Mroz; William C. Faquin; John R. Clark; Shahnaz Begum; William H. Westra; Hiroshi Wada; Paul M. Busse; Leif W. Ellisen; James W. Rocco
Preclinical Studies of Vorinostat (Suberoylanilide Hydroxamic Acid) Combined with Cytosine Arabinoside and Etoposide for Treatment of Acute Leukemias
Ken Shiozawa; Takeo Nakanishi; Ming Tan; Hong-Bin Fang; Wen-chyi Wang; Martin J. Edelman; David Carlton; Ivana Gojo; Edward A. Sausville; Douglas D. Ross
Imaging, Diagnosis, Prognosis
High VEGFR-3–positive Circulating Lymphatic/Vascular Endothelial Progenitor Cell Level Is Associated with Poor Prognosis in Human Small Cell Lung Cancer
Krisztina Bogos; Ferenc Renyi-Vamos; Judit Dobos; Istvan Kenessey; Jozsef Tovari; Jozsef Timar; Janos Strausz; Gyula Ostoros; Walter Klepetko; Hendrik Jan Ankersmit; Gyorgy Lang; Mir AliReza Hoda; Patrick Nierlich; Balazs Dome
The Expression of Three Genes in Primary Non–Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain
Helena Grinberg-Rashi; Efrat Ofek; Marina Perelman; Jozef Skarda; Pnina Yaron; Marián Hajdúch; Jasmin Jacob-Hirsch; Ninette Amariglio; Meir Krupsky; David A. Simansky; Zvi Ram; Raphael Pfeffer; Ilana Galernter; David M. Steinberg; Issachar Ben-Dov; Gideon Rechavi; Shai Izraeli
Expression of ABCC-Type Nucleotide Exporters in Blasts of Adult Acute Myeloid Leukemia: Relation to Long-term Survival
Yanping Guo; Kathleen Köck; Christoph A. Ritter; Zhe-Sheng Chen; Markus Grube; Gabriele Jedlitschky; Thomas Illmer; Mary Ayres; James F. Beck; Werner Siegmund; Gerhard Ehninger; Varsha Gandhi; Heyo K. Kroemer; Gary D. Kruh; Markus Schaich
Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group
Chiang-Ching Huang; Samantha Gadd; Norman Breslow; Colleen Cutcliffe; Simone T. Sredni; Irene B. Helenowski; Jeffrey S. Dome; Paul E. Grundy; Daniel M. Green; Michael K. Fritsch; Elizabeth J. Perlman
Genetic Signatures of HPV-related and Unrelated Oropharyngeal Carcinoma and Their Prognostic Implications
Jens P. Klussmann; Jeroen J. Mooren; Martin Lehnen; Sandra M.H. Claessen; Markus Stenner; Christian U. Huebbers; Soenke J. Weissenborn; Inga Wedemeyer; Simon F. Preuss; Jos M.J.A.A. Straetmans; Johannes J. Manni; Anton H.N. Hopman; Ernst-Jan M. Speel
Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer
Robert K. Nam; William W. Zhang; John Trachtenberg; Arun Seth; Laurence H. Klotz; Aleksandra Stanimirovic; Sanoj Punnen; Vasundara Venkateswaran; Ants Toi; D. Andrew Loblaw; Linda Sugar; Katherine A. Siminovitch; Steven A. Narod
Dynamic Spectral Imaging: Improving Colposcopy
William P. Soutter; Emmanuel Diakomanolis; Deirdre Lyons; Sadaf Ghaem-Maghami; Tosin Ajala; Dimitrios Haidopoulos; Dimitrios Doumplis; Costas Kalpaktsoglou; Gerasimos Sakellaropoulos; Suzan Soliman; Karen Perryman; Vicky Hird; C. Hilary Buckley; Kitty Pavlakis; Sofia Markaki; Roberto Dina; Vourneen Healy; Costas Balas
Cancer Therapy: Clinical
Cancer Prevention and Susceptibility
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds